Our Blog

Medibio (ASX:MEB) objective depression diagnosis and management

29 Jun 2018 – Medibio Limited (ASX:MEB) Senior Vice President, Corporate Health, Peta Slocombe discusses the company’s suite of measurement tools, which use circadian biometrics to objectively screen, diagnose, monitor and manage mental health conditions.


Source: Finance News Network

Share this post